首页 | 本学科首页   官方微博 | 高级检索  
检索        


A controlled study of a specific MAO A reversible inhibitor (R011-1163) and amitriptyline in depressive illness
Authors:T R Norman  D Ames  G D Burrows  B Davies
Institution:1. Department of Psychiatry, University of Melbourne, Austin and Larundel Hospitals, Heidelberg, Vic. 3084 Australia;2. Royal Melbourne Hospital, Parkville, Vic. 3052 Australia
Abstract:A double blind comparative study of amitriptyline and a new reversible MAO A inhibitor R011-1163 was conducted in 25 depressed inpatients over 4 weeks. Response to treatment was assessed with the Hamilton depression rating scale, the Carroll depression self rating scale and the Visual analogue scale. Both drugs produced significant changes in depressive symptomatology (P less than 0.01, MANOVA) and there were no statistically significant differences between drugs (P greater than 0.05 MANOVA). Side effects were of mild to moderate severity with dry mouth the most commonly reported side effect of amitriptyline and vague, generalised headache in patients, treated with R011-1163.
Keywords:Amitriptyline  Depression  MAO A inhibitor  R011-1163  Side effects  Symptomatology
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号